MiR-128-3p Inhibits Apoptosis and Inflammation in LPS-induced Sepsis by Targeting TGFBR2
Overview
Affiliations
Background: Sepsis is a systemic inflammatory response that can lead to the dysfunction of many organs. The aberrant expression of miRNAs is associated with the pathogenesis of sepsis. However, the biological functions of miR-128-3p in sepsis remain largely unknown, and its mechanism should be further investigated. This study aimed to determine the regulatory network of miR-128-3p and TGFBR2 in lipopolysaccharide (LPS)-induced sepsis.
Methods: The expression levels of miR-128-3p and transforming growth factor beta receptors II (TGFBR2) were detected by quantitative polymerase chain reaction (qPCR). The protein levels of TGFBR2, Bcl-2, Bax, cleaved caspase 3, Smad2, and Smad3 were measured by western blot. Cell apoptosis was analyzed by flow cytometry. Cytokine production was detected by enzyme-linked immunosorbent assay (ELISA). The binding sites of miR-128-3p and TGFBR2 were predicted by Targetscan online software and confirmed by dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay.
Results: The level of miR-128-3p was decreased, and TGFBR2 expression was increased in serum samples of sepsis patients and LPS-induced HK2 cells. Overexpression of miR-128-3p or knockdown of TGFBR2 ameliorated LPS-induced inflammation and apoptosis. Moreover, TGFBR2 was a direct target of miR-128-3p, and its overexpression reversed the inhibitory effects of miR-128-3p overexpression on inflammation and apoptosis in LPS-induced HK2 cells. Besides, overexpression of miR-128-3p downregulated TGFBR2 to suppress the activation of the Smad signaling pathway.
Conclusion: miR-128-3p could inhibit apoptosis and inflammation by targeting TGFBR2 in LPS-induced HK2 cells, which might provide therapeutic strategy for the treatment of sepsis.
The Role of MicroRNA in the Pathogenesis of Acute Kidney Injury.
Bakinowska E, Kielbowski K, Pawlik A Cells. 2024; 13(18.
PMID: 39329743 PMC: 11444149. DOI: 10.3390/cells13181559.
Cao X, Ge J, Ma Y, Li H, Han W, Lamont S Animals (Basel). 2024; 14(15).
PMID: 39123803 PMC: 11311048. DOI: 10.3390/ani14152277.
Camaya I, Hill M, Sais D, Tran N, OBrien B, Donnelly S J Diabetes Res. 2024; 2024:8555211.
PMID: 39022651 PMC: 11254460. DOI: 10.1155/2024/8555211.
Modes of action and diagnostic value of miRNAs in sepsis.
Antonakos N, Gilbert C, Theroude C, Schrijver I, Roger T Front Immunol. 2022; 13:951798.
PMID: 35990654 PMC: 9389448. DOI: 10.3389/fimmu.2022.951798.
Hao W, Lin F, Shi H, Guan Z, Jiang Y Bioengineered. 2021; 12(2):11664-11676.
PMID: 34872453 PMC: 8810017. DOI: 10.1080/21655979.2021.2000199.